BSX - Conference and earnings call announcements

MARLBOROUGH, Mass., March 6, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event and live webcast on Saturday, March 28, 2026, at 6:30 p.m. ET / 5:30 p.m. CT to discuss key clinical data presented earlier that day at the 75th Annual Scientific Session of the American College of Cardiology. The event will be hosted by Dr. Kenneth Stein, senior vice president and global chief medical officer, Dr. Brad Sutton, chief medical officer, AF solutions and Dr. Michael R. Jaff, vice president and chief medical officer, vascular therapies. The live web

MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET. A live webcast and replay of the session will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hou

MARLBOROUGH, Mass., Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in two upcoming investor conferences. On November 18, 2025, Kenneth Stein, M.D., senior vice president and global chief medical officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at Wolfe Research's 7th Annual Healthcare Conference. The session will begin at approximately 8:00 a.m. ET. On December 2, 2025, Joe Fitzgerald, executive vice president and group president, Cardiology

MARLBOROUGH, Mass., May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in two upcoming investor conferences in May. On May 13, 2025, Dan Brennan, executive vice president and chief financial officer, and Joe Fitzgerald, executive vice president and group president, Cardiology, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2025 Health Care Conference. The session will begin at approximately 8:00 a.m. PT / 11:00 a.m. ET. On May 28, 2025, Mike Mahoney, chairman and chief executive officer,

MARLBOROUGH, Mass., Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025. Dan Brennan, executive vice president and chief financial officer, Art Butcher, executive vice president and group president, MedSurg and Asia Pacific, and Kenneth Stein, M.D., senior vice president and chief medical officer, will participate in a 30-minute fireside chat with the host analyst at approximately 9:10 a.m. ET. A live webcast and replay of the session will be accessible at htts://inve

MARLBOROUGH, Mass., Nov. 5, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in the 2024 UBS Global Healthcare Conference on Tuesday, November 12, 2024. Nick Spadea-Anello, president, Electrophysiology, and Jon Monson, senior vice president, Investor Relations, will participate in a 35-minute question-and-answer session with the host analyst at approximately 7:15 a.m. PT / 10:15 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour followin

MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Wells Fargo's 2024 Healthcare Conference on Wednesday, September 4, 2024. Mike Mahoney, chairman and chief executive officer, and Dr. Brad Sutton, chief medical officer, Atrial Fibrillation Solutions, will participate in a 35-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostonscientific.com. The replay will be available approximately one hour foll

MARLBOROUGH, Mass., May 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in two upcoming investor conferences in May. On May 14, 2024, Dan Brennan, executive vice president and chief financial officer, and Ken Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at Bank of America's 2024 Health Care Conference. The session will begin at approximately 8:40 a.m. PT / 11:40 a.m. ET. On May 29, 2024, Mike Mahoney, chairman and chief executive officer,

For Immediate Release: March 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a letter of enforcement discretion for certain qualified health claims regarding the consumption of yogurt and the reduced risk of type 2 diabetes. The letter states that the FDA does not intend to object to the use of these claims, provide

MARLBOROUGH, Mass., Feb. 5, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in TD Cowen's 44th Annual Health Care Conference on Wednesday, March 6, 2024. Mike Mahoney, chairman and chief executive officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the

MARLBOROUGH, Mass., May 15, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023. Mike Mahoney, chairman and chief executive officer, will participate in a 50-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EDT. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. The replay of the webcast will be accessible at investors.bostonscientific

MARLBOROUGH, Mass., Feb. 13, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Wednesday, March 1, 2023. Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 40-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscient

MARLBOROUGH, Mass., Aug. 16, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in two upcoming investor events. On Wednesday, September 7, 2022, Mike Mahoney, chairman and chief executive officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute fireside chat with the host analyst at the Wells Fargo 2022 Healthcare Conference. The session will begin at approximately 3:10 p.m. EDT. On Sunday, September 18, the company will host an investor event and live webcast from 9:00 a.m. – 10:00 a.m. EDT at the 34th Trans

MARLBOROUGH, Mass., May 2, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12. Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at approximately 8:00 a.m. PT. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. The replay of the we

MARLBOROUGH, Mass., May 24, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) will participate in Bernstein's 37th Annual Strategic Decisions Conference on Friday, June 4, 2021. Mike Mahoney, chairman and chief executive officer, Susie Lisa, vice president, Investor Relations, and Lauren Tengler, director, Investor Relations will participate in a virtual 45-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EDT.  A live webcast of the session will be available on the Investor Relations section of the Boston Scientific webs

MARLBOROUGH, Mass., (May 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On May 11, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 35-minute question-and-answer session with the host analyst at the virtual 2021 Bank of America Health Care Conference. The session will begin at approximately 9:30 a.m. EDT. On May 25, 2021, Jeff Mirviss, executive vice president and president, Peripheral Interventions; Peter P

MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the virtually held 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Mike Mahoney, chairman and chief executive officer, will present at 8:20 a.m. EST. At approximately 8:40 a.m. EST, Mahoney will be joined by Dan Brennan, executive vice president and chief financial officer, Dr. Ian Meredith, AM, executive vice president and global chief medical officer, and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with the host analyst. On Wednesday, February 3, 2021 Boston Scientific will webcast its conference call discussing f